Compare WEN & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEN | IRMD |
|---|---|---|
| Founded | 1969 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2000 | 2014 |
| Metric | WEN | IRMD |
|---|---|---|
| Price | $7.45 | $96.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 22 | 1 |
| Target Price | $8.84 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 29.6M | 126.0K |
| Earning Date | 05-08-2026 | 05-01-2026 |
| Dividend Yield | ★ 8.28% | 0.95% |
| EPS Growth | N/A | ★ 16.67 |
| EPS | 0.12 | ★ 0.45 |
| Revenue | ★ $2,176,891,000.00 | $83,814,000.00 |
| Revenue This Year | $2.26 | $12.38 |
| Revenue Next Year | $0.94 | $11.31 |
| P/E Ratio | ★ $64.83 | $222.76 |
| Revenue Growth | N/A | ★ 14.43 |
| 52 Week Low | $6.07 | $55.11 |
| 52 Week High | $12.00 | $107.90 |
| Indicator | WEN | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.77 | 53.17 |
| Support Level | $6.53 | $90.62 |
| Resistance Level | $8.67 | $97.63 |
| Average True Range (ATR) | 0.79 | 3.58 |
| MACD | 0.05 | 0.45 |
| Stochastic Oscillator | 38.91 | 48.31 |
The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.